| |   | | | | By Ed Silverman Adobe A long-acting injectable to prevent HIV has generated hope. But an analysis suggests as priced, it isn't cost-effective compared to daily pills. Read More | | By Nicholas Florko Adobe Biden promised to overhaul the way federal prisons respond to Covid. But a year in, very little has changed, and now Omicron is surging. Read More | | By Lev Facher Win McNamee/Getty Images Biden has been pledging to "cure" cancer for the past six years, beginning with his moonshot. His new effort is far more modest. Read More | | Sponsor content by STAT Events The STAT Breakthrough Science Summit At this March 31 event, executives, researchers, scientists, and investors will take the stage to discuss the technologies and procedures at the cutting edge of health and medicine. Get your ticket now to learn about the latest efforts to battle diseases and help patients. | | By Angus Chen Wellcome Collection Researchers reported this week that the first two patients treated with CAR-T therapy remained cancer-free for a decade. Read More | |
No comments